AQUEOUS FILM COATING STUDIES OF SUSTAINED-RELEASE NICOTINIC-ACID PELLETS - AN INVITRO EVALUATION

被引:11
|
作者
SHEEN, PC
SABOL, PJ
ALCORN, GJ
FELD, KM
机构
[1] Rhone-Poulenc Barer Central Research, Horsham, PA
关键词
D O I
10.3109/03639049209069302
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Numerous batches of nicotinic acid (niacin) pellets were coated to determine the optimum level of Sureleaser coating which would exhibit in-vitro release patterns suitable for BID dosing. Various levels of Surelease, with and without the incorporation of a hydrophilic material, were studied. It was expected that a significantly high level of Surelease would be needed to obtain the desired in-vitro dissolution release rate for the water soluble drug. However, a coating level of 1.2% Surelease coating was found to have an in-vitro dissolution profile approximating that of a BID product. Scanning electron microscopic examination has shown that the surface of coating is smooth and uniform with the coating thickness of about 2-mu-m. The 2 months stability data showed no significant changes in the dissolution profiles.
引用
收藏
页码:851 / 860
页数:10
相关论文
共 50 条
  • [1] THE BIOAVAILABILITY OF SUSTAINED-RELEASE NICOTINIC-ACID FORMULATIONS
    NEUVONEN, PJ
    ROIVAS, L
    LAINE, K
    SUNDHOLM, O
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (04) : 473 - 476
  • [2] Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin
    Zhao, Xingna
    Li, Guofei
    Zhang, Lili
    Tao, Xiaoguang
    Guan, Tingting
    Hong, Mo
    Tang, Xing
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 400 (1-2) : 42 - 48
  • [3] THE PREVALENCE OF SIDE-EFFECTS WITH REGULAR AND SUSTAINED-RELEASE NICOTINIC-ACID
    GIBBONS, LW
    GONZALEZ, V
    GORDON, N
    GRUNDY, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 99 (04): : 378 - 385
  • [4] FULMINANT HEPATIC-FAILURE AFTER INGESTION OF SUSTAINED-RELEASE NICOTINIC-ACID
    MULLIN, GE
    GREENSON, JK
    MITCHELL, MC
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 111 (03) : 253 - 255
  • [5] LOW-DOSE SUSTAINED-RELEASE NICOTINIC-ACID AS AN EFFECTIVE HYPOLIPIDEMIC AGENT IN MAN
    FLEISCHMAN, AI
    BIERENBAUM, ML
    STIER, A
    [J]. FEDERATION PROCEEDINGS, 1975, 34 (03) : 248 - 248
  • [6] EFFECT OF MULTIPLE FILM COVERAGE IN SUSTAINED-RELEASE PELLETS
    WOUESSIDJEWE, D
    DEVISSAGUET, JP
    CARSTENSEN, JT
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (01) : 7 - 25
  • [7] LOW-DOSE SUSTAINED-RELEASE NICOTINIC-ACID (TRI-B3) AND LIPOPROTEIN(A)
    LEPRE, F
    CAMPBELL, B
    CRANE, S
    HICKMAN, P
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (01): : 133 - 133
  • [8] Understanding the release performance of pellets with hydrophobic inclusions in sustained-release coating
    Hiew, Tze Ning
    Tan, Desiree Li Hui
    Tiang, Yi Long
    Heng, Paul Wan Sia
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 557 : 229 - 237
  • [9] Application of terahertz pulsed imaging to analyse film coating characteristics of sustained-release coated pellets
    Haaser, M.
    Karrout, Y.
    Velghe, C.
    Cuppok, Y.
    Gordon, K. C.
    Pepper, M.
    Siepmann, J.
    Rades, T.
    Taday, P. F.
    Strachan, C. J.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 457 (02) : 521 - 526
  • [10] Preparation and Evaluation of Sustained-Release Doxazosin Mesylate Pellets
    Ha, Jung-Myung
    Kim, Ju-Young
    Oh, Tack-Oon
    Rhee, Yun-Seok
    Chi, Sang-Cheol
    Kuk, Hyon
    Park, Chun-Woong
    Park, Eun-Seok
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2013, 61 (04) : 371 - 378